1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Neuroblastoma: new trials by email Literature Review of Neuroblastoma trials Research Report on Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. Naxitamab - Neuroblastoma | Phase 4 | Not yet recruiting | SciClone Pharmaceuticals | 62 | 2023-10-31 | 2023-09-21 |
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. Ga68-DOTATATE-PET/MRI - CNS Tumors, Meningioma | Phase 4 | Recruiting | Weill Medical College of Cornell University | 200 | 2019-09-04 | 2025-11-21 |
| G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor GM-CSF, G-CSF, GM-CSF and G-CSF - Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 4 | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 405 | 2016-09-27 | 2018-10-17 |
| Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation itraconazole - Neuroblastoma, Brain Tumor | Phase 4 | Completed | Samsung Medical Center | 100 | 2006-04-01 | 2008-11-19 |
Retinoblastoma (2) · Astrocytoma (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Ganglioglioma (1) · Ganglioneuroma (1) · Glioblastoma (1) · Glioma (1) · Hemangioblastoma (1) · Hepatoblastoma (1) · Histiocytosis, Langerhans-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Glandular and Epithelial (5) · Neoplasms, Nerve Tissue (5) · Neoplasms, Neuroepithelial (5) · Neuroectodermal Tumors (5) · Neuroectodermal Tumors, Primitive (5) · Neuroectodermal Tumors, Primitive, Peripheral (5) · Neoplasms by Site (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Brain Neoplasms (2)
Granulocyte-Macrophage Colony-Stimulating Factor (2) · Granulocyte Colony-Stimulating Factor (1) · Isotretinoin (1) · Itraconazole (1) · dabrafenib (1) · naxitamab (1) · trametinib (1)
Novartis Pharmaceuticals (1) · Samsung Medical Center (1) · SciClone Pharmaceuticals (1) · Weill Medical College of Cornell University (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1)
Fang Yongjun, Ph.D (1) · Gao Fei, Ph.D (1) · Hu Shaoyan, Ph.D (1) · Jana Ivanidze, MD/Ph.D (1) · KiWoong Sung, MD, PhD (1) · Li Aimin, Ph.D (1) · Liang Changda, Master (1) · Liu Wei, Ph.D (1) · Pan Kaili, Master (1) · Sun Lirong, Ph.D (1) · Wang Hongmei, Ph.D (1) · Wen Hong, Ph.D (1) · Yuan Xiaojun, Ph.D (1) · Zhai Xiaowen, Ph.D (1)
PMID 21319349, PMID 35275019, PMID 35661809, PMID 38553990
2023 (1)